World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
58
Citations
12210
World Ranking
3518
National Ranking
22

Overview

Michael Feldman was affiliated with the Weizmann Institute of Science in Israel. Their research spanned multiple domains within medicine and economics, particularly focusing on oncology and health economics.

Their work included multiple studies on cancer screening, diagnostics, and economic evaluations in health care. Fields of study covered by the scientist were primarily Medicine and Economics, Econometrics and Finance. Subfields reflected this interdisciplinary approach with publications in Oncology, Economics and Econometrics, Endocrinology, Diabetes and Metabolism, Genetics, and Cancer Research.

Research topics explored by Michael Feldman encompassed:

  • Colorectal Cancer Screening and Detection
  • Global Cancer Incidence and Screening
  • Health Systems, Economic Evaluations, Quality of Life
  • Economic and Financial Impacts of Cancer
  • Cancer Genomics and Diagnostics
  • Diabetes Treatment and Management
  • Diabetes Management and Research

Frequent co-authors included Ali Tafazzoli (10 publications), Karen Chung (8), A. Mark Fendrick (8), Ameya Chavan (6), and Odette S. Reifsnider (5). The scientist's publications appeared often in journals such as Value in Health (7 publications), Journal of the National Comprehensive Cancer Network (4), Annals of Oncology (2), The American Journal of Managed Care (2), and Cancer Epidemiology Biomarkers & Prevention (2).

Recent papers published by Michael Feldman include:

  • Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK (2021, British Journal of Cancer)
  • Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial (2021, American Journal of Kidney Diseases)
  • Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests (2022, Patient)
  • The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA (2022, PharmacoEconomics)
  • Health state utility values by cancer stage: a systematic literature review (2021, The European Journal of Health Economics)

Best Publications

  • Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.

    D Zagury;J Bernard;R Leonard;R Cheynier

  • Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection

    R. Wallich;N. Bulbuc;G. J. Hämmerling;S. Katzav

  • HTLV-III in cells cultured from semen of two patients with AIDS

    D Zagury;J Bernard;J Leibowitch;B Safai

  • CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

    Ofer Mandelboim;Gideon Berke;Mati Fridkin;Michael Feldman

  • Interleukin 6 Gene Transfection into Lewis Lung Carcinoma Tumor Cells Suppresses the Malignant Phenotype and Confers Immunotherapeutic Competence against Parental Metastatic Cells

    Angel Porgador;Esther Tzehoval;Anne Katz;Ezra Vadai

  • C-C Chemokines, Pivotal in Protection Against HIV Type 1 Infection

    Daniel Zagury;Abderrahim Lachgar;Vida Chams;Lat S. Fall

  • Interferon α and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS

    Daniel Zagury;Abderrahim Lachgar;Vida Chams;Lat S. Fall

  • Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

    Ofer Mandelboim;Ezra Vadai;Mati Fridkin;Anne Katz-Hillel

  • Isolation and characterization of individual functionally reactive cytotoxic T lymphocytes: conjugation, killing and recycling at the single cell level

    D. Zagury;Jacky Bernard;Noelle Thierness;M. Feldman

  • Differential expression of H–2 gene products in tumour cells is associated with their metastatogenic properties

    Patrick De Baetselier;Shulamit Katzav;Eliezer Gorelik;Michael Feldman

  • Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.

    A. Porgador;Rajat Bannerji;Y. Watanabe;M. Feldman

  • THE FORMATION OF HYBRID MULTINUCLEATED MUSCLE FIBERS FROM MYOBLASTS OF DIFFERENT GENETIC ORIGIN.

    David Yaffe;Michael Feldman

  • Enhancing T lymphocytes from tumor‐bearing mice suppress host resistance to a syngeneic tumor

    A. J. Treves;C. Carnaud;N. Trainin;M. Feldman

  • MHC imbalance and metastatic spread in Lewis lung carcinoma clones

    Lea Eisenbach;Shraga Segal;Michael Feldman

  • Antigenic Specificity of Benzo[a]pyrene-Induced Sarcomas

    Amiela Globerson;Michael Feldman

  • The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells.

    Lea Eisenbach;Nurit Hollander;Lea Greenfeld;Hadas Yakor

  • Differences in Cell Surface Antigens of Tumor Metastases and Those of the Local Tumor

    Mina Fogel;Eliezer Gorelik;Shraga Segal;Michael Feldman

  • Differences in Resistance of Metastatic Tumor Cells and Cells From Local Tumor Growth to Cytotoxicity of Natural Killer Cells

    Eliezer Gorelik;Mina Fogel;Michael Feldman;Shraga Segal

  • Anti‐metastatic vaccination of tumor‐bearing mice with il‐2‐gene‐inserted tumor cells

    Angel Porgador;Bernd Gansbacher;Rajat Bannerji;Esther Tzehoval

  • Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.

    E Tzehoval;S Segal;Y Stabinsky;M Fridkin

  • The frequency of effector cells in populations containing cytotoxic T lymphocytes

    G. Berke;D. Gabison;M. Feldman

Frequent Co-Authors

Shraga Segal
Shraga Segal Ben-Gurion University of the Negev
Irun R. Cohen
Irun R. Cohen Weizmann Institute of Science
Mati Fridkin
Mati Fridkin Weizmann Institute of Science
Gideon Berke
Gideon Berke Weizmann Institute of Science
Angel Porgador
Angel Porgador Ben-Gurion University of the Negev
David Yaffe
David Yaffe Weizmann Institute of Science
Jean-François Zagury
Jean-François Zagury heSam Université
Michel Revel
Michel Revel Weizmann Institute of Science
Michael Sela
Michael Sela Weizmann Institute of Science
Leo Sachs
Leo Sachs Weizmann Institute of Science

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens opportunities not only within research and healthcare but also through complementary nursing and clinical programs. For those interested in advancing quickly, exploring the easiest absn programs to get into can be a strategic route. These programs offer accelerated pathways for registered nurses to earn bachelor’s degrees and expand their career options.

Entry-level nursing roles related to immunology careers can often begin with practical experience gained through programs identified as which lpn programs are easiest to get into. Licensed Practical Nurse programs provide foundational clinical skills applicable in immunology-focused healthcare settings.

For nurses aiming to specialize further, the easiest online nurse practitioner programs provide flexible, accessible options to gain advanced clinical training, often necessary for immunology-related patient care and treatment roles.

Additionally, mental health considerations are vital in immunology research and treatment. Prospective students should consider pmhnp programs online with best clinical placement, which focus on psychiatric mental health nursing and offer strong clinical practicum experiences to enhance care competencies.

Best Scientists Citing Michael Feldman